a visual exploration of new opportunities in thyroid cancer: targeting ret alterations
Published 3 years ago • 360 plays • Length 35:19Download video MP4
Download video MP3
Similar videos
-
1:22
targeting ret alterations with selective inhibitor blu-667
-
0:46
ret mutations in lung and thyroid cancers
-
28:43
macrocyclic tkis in treatment-naïve and pretreated fusion-positive nsclc and other tumors
-
4:05
arrow: precision targeted therapy with pralsetinib for ret fusion tumors
-
1:17
evaluating the genomic landscape of thyroid cancer
-
1:49
thor: impact of fgfr3 alterations in muc on subtype and outcomes with erdafitinib vs pembrolizumab
-
16:16
pathology of 1-piece and 3-piece intraocular lenses fixated in the ciliary sulcus
-
4:57
selpercatinib benefit for advanced, kinase inhibitor-naïve, ret-mutant medullary thyroid cancer
-
4:39
genomic alterations – a brave new world for cancer treatment? | cancer research uk
-
1:12
ret activation in thyroid cancer
-
1:52
mutations in summary
-
3:06
surgical case, itrack™ advance for canaloplasty (ed yung, usa)
-
1:03
azd2014 for treating er metastatic breast cancer – mode of action and trial results
-
1:06
tracking tumor evolution for the development of prognostic tools
-
1:35
will genomic profiling replace clinical and pathological risk factors in er breast cancer?
-
1:59
research needs to address neurologic complications of immune checkpoint inhibitor use
-
17:25
image-guided surgery using near infrared turn-on nanoprobes for precise detection of tumor margins
-
6:48
progress of refocus group’s clinical trial
-
1:41
endocrine and oncologic surgeon john t. miura, md